Sentences with phrase «about sma»
as I was just thinking about SMA and possibly moving there!
https://www.amazon.com/
«Given all that is already known about SMA scientifically, the expanded research that this funding supports will greatly advance the probability of a treatment in the near term.
About The SMA Foundation Founded in 2003, the Spinal Muscular Atrophy Foundation is a nonprofit organization dedicated to accelerating progress towards a treatment for Spinal Muscular Atrophy through targeted funding of clinical research and novel drug development efforts.
About SMA SMA is a severe neuromuscular disease characterized by the loss of motor neurons leading to progressive muscle weakness and paralysis.
More information about SMA and other neurological disorders can be found on the NINDS web site, www.ninds.nih.gov.
Information about SMA is available at http://www.ninds.nih.gov/disorders/sma/sma.htm.
About SMA Foundation The SMA Foundation is a nonprofit organization, founded in 2003, dedicated to finding a treatment and potential cure for Spinal Muscular Atrophy (SMA).
About the SMA Foundation Founded in 2003, the Spinal Muscular Atrophy Foundation is a nonprofit organization dedicated to accelerating progress towards a treatment for Spinal Muscular Atrophy through targeted funding of clinical research and novel drug development efforts.
She said she had not given Pfizer / Wyeth permission to email her and was clear she would not have signed up for emails about SMA formula even if she had visited the site that Pfizer / Wyeth alleges, which she says she had not.
If you would like any additional information about our SMAs, please fill out the form below.
Not exact matches
In 2014 the Advertising Standards Authority upheld a Baby Milk Action complaint about a misleading email promotion for the SMA toddler milk sent to members of the ASDA Baby and Toddler Club.
(For example, the Advertising Standards Authority upheld Baby Milk Action's complaints about the misleading promotion for Nestlé SMA toddler milk, shown right.
Last year the Advertising Standards Authority (ASA) upheld Baby Milk Action's complaints about a promotional email for Nestlé's SMA Toddler Milk sent to members of the ASDA Baby and Toddler Club (ASA ruling A14 - 263404).
It states that SMA «experts are passionate about educating mums on protein during the first 1,000 days of a baby's life, imparting this knowledge now can make a positive difference on babies health that will last into their adult years.»
A current campaign is hijacking the public health message about the importance of nutrition during the 1000 days from conception and branding it with SMA.
«Anyone using the new SMA PRO formula and concerned about how their child is reacting to it should contact their health worker and can be assured that all brands on the UK market are required to meet legal composition requirements.
Ironically, the bloggers recruited by Nestle are writing about the importance of protein and sharing Nestle's SMA - branded video.
In a ruling on 15 October 2014 about claims for Nestlé SMA toddler milks in an ASDA email, the ASA: «told [the companies] not to state or imply that health could be affected by not consuming a product, or to give rise to doubt the nutritional adequacy of a reference product.»
Nestlé's event was ostensibly about «food hypersensitivity management in infants and pre-school children», but is part of its strategy to promote the SMA brand in general, and its new SMA HA formula in particular.
Various health workers have contacted us about a curious market research exercise being conducted by the Millward Brown market research company into a Nestlé SMA advertising campaign.
This week (15 October 2014), the Advertising Standards Authority (ASA) published a ruling upholding our complaints about a Nestlé promotion for its SMA baby milks in one of our major supermarket chains here in the UK.
She is passionate about spreading awareness about Selective Mutism and about effective treatment techniques and is excited to contribute to the mission of SMA through her involvement on the Board of Directors.
Today, the Selective Mutism Association (SMA) website, with more than 10,000 users per month, effectively increases awareness and education about this disorder.
Company information is often misleading: Baby Milk Action has already won cases about bogus claims made for Danone and SMA formula in advertising.
After nearly three weeks of asking — and a campaign on Twitter — Tesco has finally answered Baby Milk Action's questions about an illegal promotion for Nestlé SMA formula in its stores.
When people around the UK came to us about a prominent promotion for Nestlé SMA infant formula in Tesco in January 2015, we contacted the company.
A ruling published by the Advertising Standards Authority (ASA) today (A14 - 263404) upholds Baby Milk Action complaints about a joint Nestlé and ASDA email promotion for SMA toddler milks (left).
The ASA upheld complaints from Baby Milk Action about claims in an email to the ASDA Baby and Toddler Club, promoting Nestlé SMA formula (ASA ruling A14 - 263404).
Given its concerns about Pfizer / Wyeth's misleading promotion, Baby Milk Action successfully campaigned to stop the company's SMA Baby Know How roadshow scheduled to tour shopping centres in the UK in June and July 2012 — click here.
For example, the Advertising Standards Authority upheld Baby Milk Action's complaints about a campaign for SMA formula in 2012, finding that it mislead mothers.
Baby Milk Action has also registered complaints about Wyeth's national advertising campaign that suggests its SMA formula is the best on the market.
In 2012, the ASA upheld Baby Milk Action's complaints about a national advertising campaign that claimed SMA is the best formula in a ruling against its then owner, Pfizer Nutrition.
SMA also offers other opportunities to increase awareness and information about SM through our annual conference, which typically takes place in the Fall and varies in location throughout the country, as well as through the Selective Mutism Proficiency Program, which is an intensive, interactive, and skills - based two - day training program for professionals who work with kids diagnosed with SM.
Here you can learn more about the exclusive Professional SMA member benefits.
Family and Professional memberships with SMA also provide many opportunities for interaction with experts and experienced parents and teachers among other benefits to help educate yourself and others about SM.
SMA needs your help to raise awareness about Selective Mutism.
For educators with limited time, the SMA online library provides handouts with information about SM, including suggested accommodations and classroom - based intervention strategies for maximizing learning.
The Individual / Family Membership category is for individuals and families who wish to become part of SMA's community to learn more about Selective Mutism by using the interactive features and benefits available to them.
SMA members are able to utilize SMA's comprehensive web site to become more informed about how to detect the signs of SM and learn about ways to appropriately find help and support.
SMA offers a wealth of resources for parent use in informing professionals, teachers and others who interact with their child about selective mutism.
About one in 8,000 children is born with some form of SMA in which mutations in both copies of the gene that code for the survival motor neuron (SMN) protein cripples its production.
For now, they wrote, researchers and clinicians will continue to share any new data about nusinersen use in SMA patients to inform future decisions, including how broadly treatment should be pursued.
«What is most fascinating about HDAC inhibitors, and not just for SMA, is that they are gene therapy without having to put the gene in,» Dr. Swoboda said.
About 1 in 6000 newborns are affected, and about 1 in 40 people carry the gene forAbout 1 in 6000 newborns are affected, and about 1 in 40 people carry the gene forabout 1 in 40 people carry the gene for SMA.
Interested parties are invited to contact the Foundation directly at www.smafoundation.org for more information about this and other licensing opportunities for SMA research.
«Instead of an image produced using an average of thousands of different particles, as is done with CryoET, SMA - STM can produce an image from a single particle in about 20 different orientations,» Gruebele said.
We are very optimistic about the potential of moving this drug to IND within the next year, and the lessons we are learning will help strengthen the SMA drug pipeline.»
Participants are asked to complete questionnaires about the symptoms, treatment, medications, and other experiences with SMA.
About AVXS - 101 AVXS - 101 is a proprietary gene therapy candidate of a one ‐ time treatment for SMA Type 1 and is the only clinical ‐ stage gene therapy in development for SMA.
SMA researcher Dr. Rashmi Kothary from Ottawa Hospital Research Institute spoke next about musculoskeletal defects in SMA.